Log In
BCIQ
Print this Print this
 

SBT102

  Manage Alerts
Collapse Summary General Information
Company Sangui BioTech International Inc.
DescriptionUndisclosed hemoglobin based product
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSepsis
Indication DetailsTreat septic shock
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today